Ness Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.3/10
Best for: same-price compounded GLP-1 injections or tablets with no membership and no auto-billing
Ness scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
then $250/mo ongoing
Tirzepatide
then $340/mo ongoing
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Ness is a women-owned online clinic for weight care, with a focus on PCOS and insulin resistance, run on the CareGLP platform with Beluga Health physicians. Compounded semaglutide, as injections or tablets, is $250 a month at any dose ($150 the first month with a code), and tirzepatide is $340 ($240 the first month). There is no membership and no auto-billing: you refill through a monthly check-in.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Ness
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Ness at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $250/mo (after intro offer) ($150 first month; $250 a month at every dose; new customers pay $150 for the first month with code YESNESS.)
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Ness
Each dimension is scored algorithmically from Ness’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.8/10At $250/mo (after intro offer), Ness runs about 35% above the $185 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide), with an intro price of $150. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.4/10Ness offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.6/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
7.5/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.3/10Ness's exact state footprint isn't published. Confirm coverage in your state before signing up.
Support10%
6.1/10Ness provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Ness review
Last checked November 2026- Confirmed current pricing across 8 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $167–$340/mo across 8 dose/plan tiers (checked November 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Ness
We walked Ness’s public signup flow in November 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1The homepage asks which weight loss medication you're interested in, then opens a 9-step intake form on the same page
- 2The form asks about your goals, past attempts, weight and height, then your state and medical history, with an 'I agree and consent' box
- 3The last step collects payment details and a shipping address; Ness says the card is charged only after a physician approves the prescription
- Every product page shows the first-month and ongoing price at any dose before you start
- Bundles are offered only to current patients or people with proof of a prior GLP-1 prescription
- Physicians review intakes within 24 to 48 hours; some states require a phone or video visit, which adds 5 to 7 days
- Refills need a monthly check-in form; there is no automatic monthly charge
Ness customer support
- Hours
- Weekdays 9am to 5pm ET; weekends chat and email only
GLP-1 medications Ness offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides Ness offers
Beyond GLP-1s, Ness also offers these peptides. Tap any for our evidence-based guide.
Pricing
Prices re-verified
$250 a month at every dose; new customers pay $150 for the first month with code YESNESS.
Offered only to existing Ness patients or people with proof of a previous GLP-1 prescription.
Daily tablets; $250 a month at every dose, $150 for the first month with code YESNESS.
Offered only to existing Ness patients or people with proof of a previous GLP-1 prescription.
$340 a month at every dose; new customers pay $240 for the first month with code YESNESS.
Offered only to existing Ness patients or people with proof of a previous GLP-1 prescription.
Daily tablets; $340 a month at every dose, $240 for the first month with code YESNESS.
Offered only to existing Ness patients or people with proof of a previous GLP-1 prescription.
Ready to get started?
Plans and promotions change often, so check Ness's current pricing and active discounts before you decide.
What we like
- Same price at every dose: semaglutide $250 and tirzepatide $340 a month, as injections or tablets
- No membership and no auto-billing; each refill follows a check-in form you submit
- First month is $150 for semaglutide or $240 for tirzepatide with code YESNESS
- Names its physician group, Beluga Health, its doctors and its four partner pharmacies
- LegitScript seal served from LegitScript's own site
- Your card isn't charged unless a physician approves the prescription
- Phone, text and email support with posted weekday hours, and no video call needed in most states
Watch-outs
- The Terms, Privacy Policy and consent links in its footer lead to pages that no longer exist
- The $167 and $227 bundle rates need 3 months paid up front and are only for current patients or people with a prior GLP-1 prescription
- If you're approved and then don't continue, you pay a medical review fee whose amount isn't listed
- No refunds once an order ships, and refund requests must be made within 10 days
- The site doesn't publish which states it serves
- Only 4 Trustpilot reviews, averaging 3.6
- Doesn't take insurance
Is Ness worth it?
Ness built its program around one core idea: same-price compounded GLP-1 injections or tablets with no membership and no auto-billing. New patients start at $150/month for the first month, but the price steps up to $250/month once that window ends, so treat the headline number as an intro offer, not the standing rate. Its standout is a needle-free oral option for people who would rather not inject.
Ness charges the same price at every dose. It also charges no membership fee and is LegitScript-certified.
How much Ness costs
- Compounded semaglutide starts at $150 for the first month, then $250/month after that, at that tier.
- Compounded tirzepatide starts at $240 for the first month, then $340/month after that, for that option.
Because Ness's headline figure is listed as “after intro offer”, we don't set it against the roughly $185 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare Ness with the month-to-month prices of the alternatives below instead.
For a direct comparison, Maximus runs semaglutide and tirzepatide from $249.99/month, so compare it with Ness before you commit.
Medications: what Ness prescribes
Ness prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two most-studied weight-loss molecules on the market today. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products, which is the standard trade-off across the compounded-GLP-1 market.
Ness's needle-free oral option appeals if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral, sublingual and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.
Who Ness is best for, and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement, so read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
Ness's intro price of $150 takes some of the cost out of the first month, but plan around the $250/month standing price, since that is what you pay from then on.
The Bottom Line
Ness scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with Ness?
From $250/mo (after intro offer). See current pricing and start your free consultation.
Ness might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Ness vs…
Ness scores7.3/10
Side-by-side pricing, medications and scores. Pick a matchup.
Ness vs Amazon One Medical
Amazon One Medical scores 8.5/10
Ness vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Ness review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Ness's current pricing
Plans from $250/mo (after intro offer). Start your free consultation to check eligibility and today's price.